arrow
F

Franco Veglio

University of Turin
H指数:39
被引数:6,232

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blood pressure variability as predictor of cancer therapy-related cardiovascular toxicity in patients with Multiple Myeloma

血压变异性作为多发性骨髓瘤患者癌症治疗相关心血管毒性的预测指标

2025-01-221
PRE
Screening of primary aldosteronism and pheochromocytoma among patients with hypertension: an Italian nationwide survey

高血压患者中原发性醛固酮增多症和嗜铬细胞瘤的筛查: 一项意大利全国性调查

2025-01-181
OAAI
Development and Validation of a UHPLC-MS/MS Method for the Simultaneous Quantification of Candesartan and Bisoprolol Together with Other 16 Antihypertensive Drugs in Plasma Samples
2024-12-040
PRE
The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study)
2024-09-192
PRE
MAY MEASURE MONTH 2022 IN ITALY: RESULTS OF A NATIONWIDE SURVEY
2024-05-010
OA
From SGAP-Model to SGAP-Score: A Simplified Predictive Tool for Post-Surgical Recurrence of Pheochromocytoma

从SGAP模型到SGAP评分: 嗜铬细胞瘤术后复发的简化预测工具

2022-06-033
OAAI
Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgery
2022-03-016
PRE
Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension
2022-01-038
OAAI
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism

盐皮质激素受体拮抗剂对原发性醛固酮增多症患者醛固酮与肾素比值的影响

2021-05-0414
OA